The findings also lay the foundations to investigate the molecular factors that determine the formation of distinct tau strains in 4R tauopathies, as well as in Alzheimer’s disease and other tauopathies where both 3R and 4R tau accumulate into insoluble deposits. This evidence concerns the gene MAPT and tauopathy.